Rani Therapeutics Inc. (RANI)
NASDAQ: RANI
· Real-Time Price · USD
0.55
-0.01 (-1.22%)
At close: Aug 15, 2025, 3:58 PM
0.55
0.00%
After-hours: Aug 15, 2025, 07:04 PM EDT
-1.22% (1D)
| Bid | 0.53 |
| Market Cap | 40.15M |
| Revenue (ttm) | 1.03M |
| Net Income (ttm) | -29.8M |
| EPS (ttm) | -0.9 |
| PE Ratio (ttm) | -0.61 |
| Forward PE | -0.67 |
| Analyst | Buy |
| Ask | 0.58 |
| Volume | 534,947 |
| Avg. Volume (20D) | 1,862,158 |
| Open | 0.57 |
| Previous Close | 0.56 |
| Day's Range | 0.54 - 0.57 |
| 52-Week Range | 0.39 - 3.75 |
| Beta | -0.01 |
About RANI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RANI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RANI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-38.92%
Rani Therapeutics Holdings shares are trading lowe...
Unlock content with
Pro Subscription
1 month ago
+8.45%
RANI stock has given up its prior gain. Rani Therapeutics shares were trading higher after the company announced it has unveiled preclinical data at ENDO 2025 for the RaniPill capsule.
